Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02897154 · ClinicalTrials.gov registry record
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
A clinical trial, sponsored by Abbott Point of Care.
- Completed
- Registry status
- 297
- Enrollment target
NCT02897154 is a clinical trial that has completed, run by Abbott Point of Care. The registered enrollment target is 297 participants.
The verdict
NCT02897154 has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
Study Summary
The objective of this study is to compare the performance of two i-STAT Analyzers in a Point-of-Care (POC) setting. The evaluation will be performed using a cartridge to test glucose, hematocrit and sodium on capillary specimens.
Interventions
- DIAGNOSTIC_TEST In-vitro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2016-05-10 |
| Est. Completion | 2017-03-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02897154
The ClinicalTrials.gov registry entry for NCT02897154 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Point of Care, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which In-vitro is the first listed.
NCT02897154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02897154 about?
NCT02897154 is a clinical study titled "Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples". The objective of this study is to compare the performance of two i-STAT Analyzers in a Point-of-Care (POC) setting. The evaluation will be performed using a cartridge to test glucose, hematocrit and sodium on capillary specimens.
What is the current status of trial NCT02897154?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2016-05-10. Estimated completion is 2017-03-15.
What interventions are being tested in trial NCT02897154?
The interventions under investigation include: In-vitro (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02897154?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.